Type 2 diabetic and alzheimer's disease mice present similar behavioral, cognitive, and vascular anomalies

Journal of Alzheimer's Disease

Volumn 35, Issue 3, 2013, Pages 623-635

  Carvalho, Cristina ^a,b   Machado, Nuno ^a,b   Mota, Paula C ^a,b   Correia, Sónia C ^a,b   Cardoso, Susana ^a,b   Santos, Renato X ^a,b   Santos, Maria S ^a,b   Oliveira, Catarina R ^a,c   Moreira, Paula I ^a,b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; behavior and cognitive function; brain vasculature; mitochondria; type 2 diabetes

Indexed keywords

AMYLOID BETA PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; VASCULAR CELL ADHESION MOLECULE 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN CORTEX; COGNITIVE DEFECT; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEAR; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 84880196052     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130005     Document Type: Article

References (52)

1. Carvalho C, Correia SC, Santos RX, Cardoso S, Moreira PI, Clark TA, Zhu X, Smith MA, Perry G (2009) Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia. J Bioenerg Biomembr 41, 433-440.
2. Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Cholerton BA, Plymate SR, Fishel MA,Watson GS, Duncan GE, Mehta PD, Craft S (2010) Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. J Alzheimers Dis 22, 569-579.
3. Toro P, Schonknecht P, Schroder J (2009) Type II diabetes in mild cognitive impairment and Alzheimer's disease: Results from a prospective population-based study in Germany. J Alzheimers Dis 16, 687-691.
4. Cheng D, Noble J, Tang MX, Schupf N, Mayeux R, Luchsinger JA (2011) Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 31, 424-430.
5. Paris D, Humphrey J, Quadros A, Patel N, Crescentini R, Crawford F, Mullan M (2003) Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: Role of inflammation. Neurol Res 25, 642-651.
6. Liu H, Zhang J (2012) Cerebral hypoperfusion and cognitive impairment: The pathogenic role of vascular oxidative stress. Int J Neurosci 122, 494-499.
7. Buizza L, Cenini G, Lanni C, Ferrari-Toninelli G, Prandelli C, Govoni S, Buoso E, Racchi M, Barcikowska M, Styczynska M, Szybinska A, Butterfield DA, Memo M, Uberti D (2012) Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. PLoS One 7, e29789.
8. Costa MS, Botton PH, Mioranzza S, Ardais AP, Moreira JD, Souza DO, Porciuncula LO (2008) Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus. Neurochem Int 53, 89-94.
9. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H (1992) A two-trial memory task with automated recording: Study in young and aged rats. Brain Res 588, 132-139.
10. Dellu F, Fauchey V, Le Moal M, Simon H (1997) Extension of a new two-trial memory task in the rat: Influence of environmental context on recognition processes. Neurobiol Learn Mem 67, 112-120.
11. Akwa Y, Ladurelle N, Covey DF, Baulieu EE (2001) The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: Distinct mechanisms? Proc Natl Acad Sci U S A 98, 14033-14037.
12. Carvalho C, Santos MS, Baldeiras I, Oliveira CR, Seica R, Moreira PI (2010) Chronic hypoxia potentiates age-related oxidative imbalance in brain vessels and synaptosomes. Curr Neurovasc Res 7, 288-300.
13. Hatefi Y, Rieske JS (1967) [41] The preparation and properties of DPNH - cytochrome c reductase (complex I-III of the respiratory chain). In Methods in Enzymology, RonaldW, Estabrook MEP, ed. Academic Press, pp. 225-231.
14. Estabrook RW (1967) [7] Mitochondrial respiratory control and the polarographic measurement of ADP : O ratios. In Methods in Enzymology, RonaldW, Estabrook MEP, ed. Academic Press, pp. 41-47.
15. Krebs HA, Holzach O (1952) The conversion of citrate into cis-aconitate and isocitrate in the presence of aconitase. Biochem J 52, 527-528.
16. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
17. Roy S, RaukA(2005) Alzheimer's disease and the 'ABSENT' hypothesis: Mechanism for amyloid beta endothelial and neuronal toxicity. Med Hypotheses 65, 123-137.
18. Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, Sakurai H, Iwamoto T (2011) Vascular risk factors are associated with faster decline of Alzheimer disease: A longitudinal SPECT study. J Neurol 258, 1295-1303.
19. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63, 1187-1192.
20. Carvalho C, Cardoso S, Correia SC, Santos RX, Santos MS, Baldeiras I, Oliveira CR, Moreira PI (2012) Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 61, 1234-1242.
21. Power DA, Noel J, Collins R, O'Neill D (2001) Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord 12, 167-170.
22. Natali A, Ferrannini E (2012) Endothelial dysfunction in type 2 diabetes. Diabetologia 55, 1559-1563.
23. Salmina AB, Inzhutova AI, Malinovskaya NA, Petrova MM (2010) Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: Neuronal and glial control. J Alzheimers Dis 22, 17-36.
24. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S (2003) New markers of inflammation and endothelial cell activation: Part I. Circulation 108, 1917-1923.
25. Frank PG, Lisanti MP (2008) ICAM-1: Role in inflammation and in the regulation of vascular permeability. Am J Physiol Heart Circ Physiol 295, H926-H927.
26. Reale M, Kamal MA, Velluto L, Gambi D, Di Nicola M, Greig NH (2012) Relationship between inflammatory mediators, Abeta levels and ApoE genotype in Alzheimer disease. Curr Alzheimer Res 9, 447-457.
27. Rozemuller JM, Eikelenboom P, Pals ST, Stam FC (1989) Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett 101, 288-292.
28. Frohman EM, Frohman TC, Gupta S, de Fougerolles A, van den Noort S (1991) Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease. J Neurol Sci 106, 105-111.
29. Rentzos M, Michalopoulou M, Nikolaou C, Cambouri C, Rombos A, Dimitrakopoulos A, Kapaki E, Vassilopoulos D (2004) Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease. J Geriatr Psychiatry Neurol 17, 225-231.
30. Blasko I, Knaus G,Weiss E, Kemmler G,Winkler C, Falkensammer G, Griesmacher A,Wurzner R, Marksteiner J, Fuchs D (2007) Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin. J Psychiatr Res 41, 694-701.
31. Locascio JJ, Fukumoto H, Yap L, Bottiglieri T, Growdon JH, Hyman BT, Irizarry MC (2008) Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol 65, 776-785.
32. Weller A, Isenmann S, Vestweber D (1992) Cloning of the mouse endothelial selectins. Expression of both E- and Pselectin is inducible by tumor necrosis factor alpha. J Biol Chem 267, 15176-15183.
33. Carter RA, Wicks IP (2001) Vascular cell adhesion molecule 1 (CD106): A multifaceted regulator of joint inflammation. Arthritis Rheum 44, 985-994.
34. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA (2003) Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10, 463-470.
35. Yan J, Zhang Z, Shi H (2012) HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol Life Sci 69, 115-128.
36. Remor AP, de Matos FJ, Ghisoni K, da Silva TL, Eidt G, Burigo M, de Bem AF, Silveira PC, de Leon A, Sanchez MC, Hohl A, GlaserV, Goncalves CA, Quincozes-Santos A, Borba Rosa R, Latini A (2011) Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: Involvement of advanced glycosylated end products. Biochim Biophys Acta 1812, 1460-1471.
37. Zhang H, Zhang HM, Wu LP, Tan DX, Kamat A, Li YQ, Katz MS, Abboud HE, Reiter RJ, Zhang BX (2011) Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice. J Pineal Res 51, 338-344.
38. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age inADtransgenic mice. Neurobiol Aging 30, 1574-1586.
39. Rhein V, Baysang G, Rao S, Meier F, Bonert A, Muller-Spahn F, Eckert A (2009) Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 29, 1063-1071.
40. Davidson SM, DuchenMR(2007) Endothelial mitochondria: Contributing to vascular function and disease. Circ Res 100, 1128-1141.
41. Bailey KR, Crawley JN (2009) Anxiety-related behaviors in mice. In: Methods of Behavior Analysis in Neuroscience, 2nd edition, Buccafusco JJ, ed. CRC Press, Boca Raton (FL), Chapter 5.
42. Sterniczuk R, Antle MC, Laferla FM, Dyck RH (2010) Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 2. Behavioral and cognitive changes. Brain Res 1348, 149-155.
43. Chung JA, Cummings JL (2000) Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: Characteristics and treatment. Neurol Clin 18, 829-846.
44. Di Iulio F, Palmer K, Blundo C, Casini AR, Gianni W, Caltagirone C, SpallettaG(2010) Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes. Int Psychogeriatr 22, 629-640.
45. Drevets WC, Rubin EH (1989) Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 25, 39-48.
46. Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M, Carta A (1996) Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 153, 1438-1443.
47. Dinel AL, Andre C, Aubert A, Ferreira G, Laye S, Castanon N (2011) Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One 6, e24325.
48. Jung HS, Lee MS (2010) Role of autophagy in diabetes and mitochondria. Ann N Y Acad Sci 1201, 79-83.
49. Atiea JA, Moses JL, Sinclair AJ (1995) Neuropsychological function in older subjects with non-insulin-dependent diabetes mellitus. Diabet Med 12, 679-685.
50. Mogi N, Hattori A, Ushida C, Umegaki H, Miura H, Iguchi A (2001) [Cognitive function and brain atrophy in elderly type 2 diabetic patients in comparison with non-diabetic elderly subjects]. Nihon Ronen Igakkai Zasshi 38, 388-392.
51. KesselsRP,MollemanPW, OostermanJM(2011) Assessment of working-memory deficits in patients with mild cognitive impairment and Alzheimer's dementia using Wechsler's Working Memory Index. Aging Clin Exp Res 23, 487-490.
52. Li ZG, Zhang W, Sima AA (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56, 1817-1824.